Terence Rabbitts englischer Molekularbiologe und Hochschullehrer
Rabbitts, T. H.
Rabbitts, T. H. (Terry H.)
VIAF ID: 164745939 (Personal)
Permalink: http://viaf.org/viaf/164745939
Preferred Forms
-
-
100 1 _ ‡a Rabbitts, T. H.
-
100 1 _ ‡a Rabbitts, T. H. (sparse)
-
-
100 1 _ ‡a Rabbitts, T. H. ‡q (Terry H.)
-
-
-
100 0 _ ‡a Terence Rabbitts ‡c englischer Molekularbiologe und Hochschullehrer
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Chromosomal translocations and genome rearrangements in cancer, 2015: |
![]() ![]() |
Immunoglobulin genes, c1989: |
![]() ![]() ![]() ![]() ![]() ![]() |
Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation |
![]() |
Intracellular antibodies and challenges facing their use as therapeutic agents |
![]() |
Intracellular antibody capture: A molecular biology approach to inhibitors of protein-protein interactions |
![]() |
Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy. |
![]() |
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein. |
![]() |
The invertor knock-in conditional chromosomal translocation mimic |
![]() |
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe |
![]() |
Leukaemia lineage specification caused by cell-specific Mll-Enl translocations |
![]() |
The LIM domain: a new structural motif found in zinc-finger-like proteins. |
![]() |
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target |
![]() |
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins |
![]() |
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells |
![]() |
Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves |
![]() |
LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. |
![]() |
LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia. |
![]() |
Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. |
![]() |
LMO2 at 25 years: a paradigm of chromosomal translocation proteins |
![]() |
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal |
![]() |
The mechanism of chromosome 14 inversion in a human T cell lymphoma. |
![]() |
The mitochondrial ribosome of baby-hamster kidney cells |
![]() |
Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis |
![]() |
Molecular analysis of a new translocation, t(X;14)(q28;q11), in premalignancy and in leukaemia associated with ataxia telangiectasia |
![]() |
Molecular cloning of a zinc finger protein which binds to the heptamer of the signal sequence for V(D)J recombination. |
![]() |
Molecular cloning of putative odorant-binding and odorant-metabolizing proteins. |
![]() |
Molecular Probing of Disease Susceptibility Genes in Myasthenia Gravis Patients: An Analysis of T-Cell Receptor and HLA Class II Genes Using Restriction Fragment Length Polymorphism |
![]() |
Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia |
![]() |
Multiple methylation-free islands flank a small breakpoint cluster region on 11p13 in the t(11;14)(p13;q11) translocation |
![]() |
A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS |
![]() |
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice |
![]() |
Of methods and mapping |
![]() |
The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. |
![]() |
Organization of the human CD3 locus on chromosome 11 |
![]() |
PCRPi: Presaging Critical Residues in Protein interfaces, a new computational tool to chart hot spots in protein interfaces |
![]() |
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS |
![]() |
Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias |
![]() |
Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia |
![]() |
Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer |
![]() |
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism |
![]() |
Quantitation of antibody genes by molecular hybridization |
![]() |
Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. |
![]() |
Redox Regulation of in Vitro DNA-binding Activity by the Homeodomain of the Isl-1 Protein |
![]() |
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. |
![]() |
The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. |
![]() |
The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development |
![]() |
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion |
![]() |
The role of Slit-Robo signaling in the generation, migration and morphological differentiation of cortical interneurons |
![]() |
Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol |
![]() |
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities |
![]() |
Selection of complementary single-variable domains for building monoclonal antibodies to native proteins |
![]() |
Selection of functional single domain antibody fragments for interfering with protein-protein interactions inside cells: a "one plasmid" mammalian two-hybrid system |
![]() |
Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture. |
![]() |
The sequence at the 3' terminus of mouse immunoglobulin secreted mu chain messenger RNA determined from cloned cDNA. |
![]() |
Sequence of the D beta 2-J beta 2 region of the human T-cell receptor beta-chain locus |
![]() |
The sequence of the human immunoglobulin mu-delta intron reveals possible vestigial switch segments. |
![]() |
Sequential gene targeting to make chimeric tumor models with de novo chromosomal abnormalities |
![]() |
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome |
![]() |
Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies |
![]() |
Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain |
![]() |
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange. |
![]() |
Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta |
![]() |
A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia |
![]() |
Sub-proteome differential display: single gel comparison by 2D electrophoresis and mass spectrometry |
![]() |
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model |
![]() |
T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes |
![]() |
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. |
![]() |
The T cell oncogene Tal2 is necessary for normal development of the mouse brain |
![]() |
T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity |
![]() |
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2 |
![]() |
Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. |
![]() |
Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia |
![]() |
Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. |
![]() |
Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. |
![]() |
Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene. |
![]() |
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS |
![]() |
Turbo-screening of bacterial colonies using microwave denaturation on paper filters |
![]() |
Unusual forms of T cell gamma mRNA in a human T cell leukemia cell line: implications for gamma gene expression |
![]() |
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. |
![]() |